Screener
Vaxcyte, Inc. PCVX Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The source filing: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001649094-26-000017
| Line item | March 31,2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $260,843 | $173,959 |
| Short-term investments | 1,476,335 | 1,387,000 |
| Prepaid expenses and other current assets | 76,310 | 66,402 |
| Total current assets | 1,813,488 | 1,627,361 |
| Property and equipment, net | 260,695 | 257,370 |
| Operating lease right-of-use assets | 113,103 | 116,009 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Vaxcyte, Inc.'s short-term investments?
- Vaxcyte, Inc. (PCVX) reported short-term investments of $1.48B in Q1 2026.
- How has Vaxcyte, Inc.'s short-term investments changed year-over-year?
- Vaxcyte, Inc.'s short-term investments increased by 11.4% year-over-year, from $1.32B to $1.48B.
- What is the long-term trend for Vaxcyte, Inc.'s short-term investments?
- Over 4 years (2021 to 2025), Vaxcyte, Inc.'s short-term investments has grown at a 67.3% compound annual growth rate (CAGR), from $176.99M to $1.39B.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Vaxcyte, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude